Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cardiovascular > Drugs for Ischaemic Heart Disease > Flashcards

Drugs for Ischaemic Heart Disease Flashcards

1
Q

How many mitochondria are in each cardiomyocyte?

A

5000

Generate ATP- far more than any other organ of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is preload?

A

Volume of blood in the ventricles at the end of diastole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is preload determined by?

A

Blood volume

Venous tone, capacity of the venous circulation to hold blood (constriction= more return)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is preload increased by?

A

Sympathetic NS activation
Renal failure
Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is afterload?

A

Resistance the heart must overcome to circulate blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is afterload determined by?

A

Tone in arterial circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is afterload increased by?

A

SNS activation

Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes narrowing of the coronary arteries?

A

Atheroma
Coronary artery spasm (smooth muscle spontaneously constrict)
leads to ischaemic heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do stable plaques lead to?

A

Lack of oxygen and chest pain (angina)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What leads to myocardial infarction?

A

Unstable plaque and thrombus

MINOCA= myocardial infarction non obstructed coronary artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does vascular endothelium regulate?

A

Blood vessel tone
Permeability
Leukocyte adhesion, platelet aggregation and tendency for thrombus formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What occurs to lead to lesion formation?

A

Changes in endothelial function

Leukocyte adhesion and migration as endothelial permeability increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the causes of endothelial dysfunction?

A
  • Elevated and modified low density lipoprotein (in familial hypercholesterolaemia)
  • Oxygen free radicals (smoking, hypertension, activated inflammatory cells)
  • Infectious microorganisms (herpes virus, chlamydia pneumoniae, h. pylori)
  • physical damage and gene activation by turbulent flow, high blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the risk factors for endothelial dysfunction?

A

Diabetes, ageing, male (females after menopause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are foam cells?

A

Macrophages that take up low density lipoprotein oxidised by interaction with oxygen free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the formation of a fatty streak

A 
Inflammatory cell activation
Smooth muscle migration
Foam cell formation
T cell activation
Adherence and aggregation of platelets
Adherence and entry of leukocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the formation of advanced complex lesion

A

Macrophage accumulation
Formation of necrotic core
Fibrous cap formation- stability key to prognosis
Healing response to injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the difference in outcome between unstable and stable angina?

A 
Stable= chest pain
Unstable= cap rupture or erosion= thrombus= heart attack/MI, stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which drug lowers cholesterol and low density lipoprotein?

A

Statins

simvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is LDL formed?

A

HMG CoA into mevalonate via HMG CoA reductase (rate determining step in liver)
Mevalonate precursor for cholesterol, then LDL
binds to LDL receptors for clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the mechanism of statin drug action?

A

statins are inhibitors of HMG CoA reductase

Increase expression of LDL receptors (so more clearance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the other effects of statins (pleiotropic)?

A 
Improved endothelial function
Inhibition of inflammation
Plaque stabilisation
Inhibition of thrombus formation
(mevalonate compounds involved in intracellular signal transduction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What other lipid lowering drugs are used with or as an alternative to statins?

A

Fibrates (bezafibrate, gemfibrozil, fenofibrate)

ezetimibe

24
Q

Describe fibrates

A

Activate intracellular PPARa (peroxisome proliferator receptor a)
Decrease circulating very low density lipoprotein and triglyceride, only very small effect on LDL but also increase protective high density lipoprotein

25
Q

Describe ezetimibe

A

Lowers cholesterol absorption from small intestine vis action in epithelial cells

26
Q

What is angina pectoris?

A

Intermittent chest pain caused by mismatch between demand of oxygen by the heart and supply of oxygen to the heart (stimulates chemoreceptors- chest pain)

27
Q

What is oxygen supply decreased by?

A

Coronary artery disease

Anaemia

28
Q

What is oxygen demand increased by?

A

Exercise
Tachycardia
Hypertension

29
Q

What is the aim of angina treatment?

A

Reduce demand or increase supply

Reduce demand by reduce heart rate/ force of contraction/ preload/ afterload

30
Q

Describe acute angina treatment

A

Rest

Rapid acting organic nitrate (glyceryl trinitrate)

31
Q

Describe prophylactic angina treatment

A

Targets blood vessels- longer lasting nitrate/ K (ATP) channel opener
Targets heart- beta adrenoreceptor antagonist/ calcium antagonist/ funny channel blocker

32
Q

How do nitrates affect the blood vessels?

A

NO in endothelial cells into smooth muscle cell- guanylate cyclase converts GTP into cGMP= relaxation (reduces availability for Ca 2 for contraction)
Veins more than arteries

33
Q

What are the effects of nitrates on venous circulation?

A

Dilate veins, decrease venous return and preload on heart, reduce oxygen demand

34
Q

What are the effects of nitrates on arterioles and coronary arteries?

A

Dilate and reduce afterload on heart therefore reduce oxygen demand
Coronary= improves supply (coronary spasm)

35
Q

What are examples of nitrates?

A
  • Glyceryl trinitrate- acute (sub-lingual or spray), chronic use leads to tolerance (loss of responsiveness) rapid action
  • Isosorbide dinitrate- slow release patch/ oral, can be prophylactic, nitrate free periods required, longer acting
36
Q

What are the effects of nicorandil?

A

Reduces preload and afterload on heart and therefore oxygen demand
Dilates coronary arteries and can increase oxygen supply in coronary spasm

37
Q

What are the mechanisms of nicorandil?

A 
Causes blood vessel dilation by opening ATP sensitive K+ channels in smooth muscle cells
Nitrate moiety (releases NO) in structure therefore additional vasodilator action
38
Q

What are the mechanisms and effects of beta adrenoreceptor antagonists (like atenolol)?

A
  • Blocks cardiac beta 1 adrenoreceptor= reduce heart rate and therefore oxygen demand
  • Blocks renal beta 1 adrenoreceptor= reduce blood volume by reducing renin release and activation of RAAS, reduce preload and therefore oxygen demand
39
Q

What does RAAS stand for?

A

Renin Angiotensin Aldosterone System

40
Q

What are the mechanisms and effect of ivabradine?

A

Blocks ‘funny current’ in sino-atrial node cells= reduces rate of spontaneous depolarisation during action potential generation- reduce heart rate so oxygen demand
(Less side effects than beta blockers)

41
Q

What are the mechanisms and effects of calcium antagonists?

A

nifedipine, diltiazem
Prevent opening of voltage dependent Ca 2 channels= prevents Ca 2 entry into cardiac muscle cells from extracellular space= reduce availability to contractile apparatus= reduce force of contraction and therefore oxygen demand

42
Q

Describe thrombus formation

A

Endothelial cells produce anti-thrombotic mediators, damage= collagen exposure= platelet activation (change shape and stick together)= coagulation cascade= fibrin

43
Q

What are anti-thrombotic drugs?

A

Taken prophylactically to reduce risk of thrombus if atherosclerotic plaque ruptures, in patients at high risk or already had MI

  • Anti-platelet (aspirin, clopidogrel, vorapaxar)
  • Anti-coagulant (warfarin, rivaroxaban)
44
Q

Describe platelet activation

A

Stimulus (collagen)- thrombin activates coagulation cascade- Arachidonic acid via phospholipaseA2- cyclic endoperoxidases via cyclooxygenase (COX)- TxA2 prostaglandin via Tx synthetase- TxA2 receptor= increase in iCa 2+ so activation of platelet

45
Q

What is the mechanism of anti-platelet drugs?

A

Thrombin antagonist

COX inhibitor

46
Q

How do platelets further increase activation?

A

Activated platelets change shape and release contents of granules- adenosine diphosphate (ADP)

47
Q

How do activated platelets stabilise the thrombus?

A

Platelets express glycoprotein 2b/3a receptors for attachment of fibrin, from coagulation cascade

48
Q

What other mechanisms of anti-platelet drugs have directly on the platelet?

A 
P2Y12 receptor antagonists to block ADP so less platelet aggregation
abciximab antibody (IV)- blocks fibrin binding to gp2b/3a
49
Q

What are the overall mechanisms of anti-platelet drugs?

A
  • COX inhibitor- aspirin- irreversible inhibition of COX, prevents formation of TxA2 and platelet activation
  • P2Y12 inhibitor- clopidogrel, ticagrelor- blocks effect of ADP and prevents platelet activation
  • Thrombin-receptor antagonist- vorapaxar- prevent activation of PAR-1 receptors on platelets
50
Q

What are the risks of anti-platelet drugs?

A

Bleeding

Newer drugs shorter acting or reversible

51
Q

What are anti-coagulant drugs and what are the types?

A

Prevent the formation of fibrin to stabilise platelet plug

  • Intravenous= heparin
  • Orally active= warfarin, rivaroxaban
52
Q

What is the action of heparin?

A

Binds to Anti-thrombin 3- released by endothelial cells naturally in response
Promotes action, reduces coagulation cascade

53
Q

What is the action of warfarin?

A

Reduces the action of enzyme reductase so less oxidised Vitamin K is converted into hydroquinone Vitamin K so less Glu converted into Glu-COOH which is involved in active factors 2,7,9,10 (prevents cofactors forming)

54
Q

What are the common indications of warfarin?

A

AF, artificial heart valves, DVT, pulmonary embolism, occasionally after MI

55
Q

What are the cons of warfarin?

A

Narrow optimal range, high risk of bleeding
Broken down in liver, enzymes induced by other drugs, environmental influences
Blood levels must be checked regularly

56
Q

What is the action of rivaroxaban?

A

Inhibits action of Xa in thrombin formation

Cardiovascular (51 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions